THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN PATIENTS RECEIVING PROPHYLACTIC ANTITHROMBOTIC REGIMENS WITH UNFRACTIONED HEPARIN OR LMWH (REVIPARIN)
M. Berrettini et al., THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN PATIENTS RECEIVING PROPHYLACTIC ANTITHROMBOTIC REGIMENS WITH UNFRACTIONED HEPARIN OR LMWH (REVIPARIN), Thrombosis and haemostasis, 1997, pp. 1674-1674